Investor Alert: BCSC Issues Warning About Previously Disciplined Person

The British Columbia Securities Commission (BCSC) has become aware that a previously disciplined person, Volkmar Guido Hable, recently changed his name to Jacob Jason Volkmar Guido DeMedici (a.k.a. Jacob Jason DeMedici).

On June 26, 2017, the Commission found that Hable, now DeMedici, contravened the Securities Act when he manipulated the shares of Samaranta Mining Corporation and when he submitted false information to a Commission investigator. On November 7, 2017, the Commission permanently banned Hable from the B.C. capital markets and ordered him to pay penalties totalling $557,596.96.  In its sanction decision, the Commission stated that Hable “represents a significant risk to our capital markets.”

DeMedici had recent dealings with a B.C. company and purports to be the founder of DeMedici Capital Partners.

The Commission urges anyone who has had dealings with Hable or DeMedici in relation to securities activity, to contact the BCSC inquiries line at 604-899-6854 or 1-800-373-6393 or through email at [email protected].

If you have any concerns about a person or company offering an investment opportunity, please contact BCSC Inquiries at 604-899-6854 or 1-800-373-6393 or through email at [email protected]. You can also file a complaint or submit a tip anonymously using the BCSC’s online complaint form.

InvestRight.org is the British Columbia Securities Commission’s investor education website.

Suggested Reading

Investor Alert: Weizhen Tang

Preparing for a possible postal service disruption

Investor Alert: Crypto-Asset "Smart Wallets" | 投資者警示: 加密资产 “智能钱包”

More Resources

Investor Alert: Warning about aggressive promotion of Revive Therapeutics

The BCSC is warning the public to exercise extreme caution about aggressive promotion of companies with products or initiatives to detect, cure or treat COVID-19.

Canadian Securities Regulators Warn Public of Coronavirus-Related Investment Scams

CSA warns investors about companies claiming to have products or services that will prevent, detect or cure coronavirus (COVID-19) infection.